Clinical Trial Update: Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating circulating cell-free tumor DNA testing to guide treatment for patients with advanced or metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING